-
Start Preamble
By Notice dated August 27, 2001, and published in the Federal Register on September 7, 2001, (66 FR 46818), Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed below:
Drug Schedule Codeine (9050) II Oxycodone (9143) II Thebaine (9333) II The firm plans to produce bulk product for distribution to its customers.
No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of Rhodes Technologies to manufacture the listed controlled substances is consistent with the public interest at this time.
DEA has investigated Rhodes Technologies to ensure that the company's registration is consistent with the public interest. This investigation included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed above is granted.
Start SignatureDated: May 21, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 02-13261 Filed 5-24-02; 8:45 am]
BILLING CODE 4410-09-M
Document Information
- Published:
- 05/28/2002
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Document Number:
- 02-13261
- Pages:
- 36917-36917 (1 pages)
- PDF File:
- 02-13261.pdf